US stocks move sideways after January job growth tops estimates

Weather - Sydney 10°C

US stocks move sideways after January job growth tops estimates

ECONOMY 11.02.2026

US stocks move sideways after January job growth tops estimates / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

Wall Street stocks moved sideways Wednesday following solid US jobs data that boosted sentiment about the economy but dented prospects for imminent Federal Reserve interest rate cuts.

Change text size:

The US economy added 130,000 jobs last month, the Department of Labor said, more than double the amount expected by analysts. Meanwhile, the jobless rate inched lower to 4.3 percent.

The report comes on the heels of recent data that has raised questions about US economic health.

"There were some investors concerned after yesterday's retail sales that this report would potentially add to some growth worries," said Angelo Kourkafas of Edward Jones. "But I think the solid numbers really alleviated some of these fears."

But the report also means "there is less urgency from the Fed to cut interest rates," Kourkafas said. "This could support the rotation that is happening with the old economy stocks benefiting while we still see some of the lingering disruption worries on the technology space."

The S&P 500 finished flat while both the Dow and Nasdaq ended marginally lower after choppy sessions.

In Europe, London's FTSE 100 gained more than one percent and set a new record high thanks to buoyant commodity prices.

Paris and Frankfurt both ended lower.

Asia's main stock markets closed higher before the US jobs report.

XTB research director Kathleen Brooks noted that the jobs data still raised concerns thanks to an annual revision that was also given Wednesday -- which showed a benchmark reduction of 862,000 positions.

"The revisions suggest there was virtually no jobs growth in the US last year," she said.

In Europe on Wednesday, shares in Heineken climbed 4.2 percent after the Dutch brewer said it would axe 6,000 jobs amid falling beer shipments.

TotalEnergies rose 3.1 percent as the French energy giant announced fresh share buybacks, helping offset news of a 17 percent drop in annual net profit.

Siemens Energy shares jumped 8.4 percent on ballooning profits as AI boosts demand for electricity.

On the downside, Dassault Systemes tumbled 20 percent after the French software group posted lower sales than expected.

Among US companies, Mattel plunged 25 percent after reporting disappointing results.

CEO Ynon Kreiz pointed to disappointing demand in December and said the toymaker's 2026 investments would crimp profits this year but "accelerate growth in top and bottom lines in 2027 and beyond."

- Key figures at around 2115 GMT -

New York - Dow: DOWN 0.1 percent at 50,121.40 (close)

New York - S&P 500: FLAT at 6,941.47 (close)

New York - Nasdaq Composite: DOWN 0.2 percent at 23,066.47 (close)

London - FTSE 100: UP 1.1 percent at 10,472.11 (close)

Paris - CAC 40: DOWN 0.2 percent at 8,313.24 (close)

Frankfurt - DAX: DOWN 0.5 percent at 24,856.15 (close)

Hong Kong - Hang Seng Index: UP 0.3 percent at 27,266.38 (close)

Shanghai - Composite: UP 0.1 percent at 4,131.98 (close)

Tokyo - Nikkei 225: Closed for a holiday

Euro/dollar: DOWN at $1.1874 from $1.1895 on Tuesday

Pound/dollar: DOWN at $1.3628 from $1.3643

Dollar/yen: DOWN at 153.14 yen from 154.39 yen

Euro/pound: DOWN at 87.13 pence from 87.19 pence

Brent North Sea Crude: UP 0.9 percent at $69.40 per barrel

West Texas Intermediate: UP 1.1 percent at $64.63 per barrel

burs-jmb/sla

N.Johns--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size:

The National Times - US stocks move sideways after January job growth tops estimates